Navigation Links
Nucleix Appoints Meirav Chovav Vice President of Strategic Affairs and to the Board of Directors
Date:8/17/2009

TEL AVIV, Israel, Aug. 17 /PRNewswire/ -- Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced today that Meirav Chovav, a veteran biotechnology industry analyst and consultant, is joining the company as Vice President of Strategic Affairs. Ms. Chovav has also been elected to the company's Board of Directors.

With more than 20 years of industry and research experience, focused on in-depth coverage and analysis of the biotechnology sector, Ms. Chovav brings astute strategic and business development perspective to Nucleix. In this newly-created position, Ms. Chovav will be responsible for overseeing corporate strategy, reporting to Elon Ganor, MD, Nucleix's Chairman and Chief Executive Officer.

"We are very pleased to add Meirav to the company's management team and to the board," said Dr. Ganor. "Meirav's rich industry knowledge and strategic vision will be extraordinarily valuable as we seek to integrate Nucleix's revolutionary insights and technology in the forensic DNA testing process."

"I am very excited to join the Nucleix team, and have this unique opportunity to resume my work in the industry as an active participant in an emerging company," said Ms. Chovav. "Nucleix's focus, breakthrough research and technology and remarkable accomplishments are very impressive. In many ways, Nucleix is reminiscent of some of the outstanding opportunities that I have had the good fortune to be associated with during my Wall Street career."

Ms. Chovav holds an MBA from Rensselaer Polytechnic Institute and an MS in molecular biology from the University of Rochester. A well-respected biotechnology research analyst, Ms. Chovav is renowned for her original coverage of large cap biotechnology companies such as AMGEN, Genentech and Biogen, in addition to many other leading life sciences companies. From 1993-2004, Ms. Chovav led co
'/>"/>

SOURCE Nucleix, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Spectral appoints new board member
2. Cellular Dynamics International Appoints Leroy Hood, M.D., Ph.D., and George Church, Ph.D., to its Scientific Advisory Board
3. China Sky One Medical, Inc. Appoints New Independent Director
4. Omeros Appoints New Vice President of Clinical Development
5. Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
6. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
7. Brookstone Pharmaceuticals Appoints New Corporate Position
8. PDI Appoints Gerald P. Belle as Lead Independent Director
9. Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
10. Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer
11. Solace Pharmaceuticals Appoints Professor David Julius, Renowned Pain Physiologist, to Scientific Advisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...EAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics In... in a randomized Phase 2B study of AEG35156, a tar...nt for multiple oncology indications. ,, The st...udy of the X-Linked Inhibitor of Apoptosis (XIAP) ...dose Cytarabine and Idarubicin in AML Following Fa...
(Date:11/19/2009)... VIENNA, Austria, November 19 AF...m on one product candidate at an unexpectedly earl... is planned to enter into,Phase II clinical trial ...ately follows the completion of two Phase I trials...sed its fast decision on the first interim,analysi...
(Date:11/18/2009)...ll. Imagine a polka-dotted postage stamp that can... by changing colors. , As reported in the Sept. ...h Suslick and his team at the University of Illino...al detection of toxic industrial chemicals (TICs) ... visualizing odors. This sensor array could be us...
(Date:11/18/2009)...E, Calif., Nov. 18 Mas...metry(TM) and Measure-Through Motion and Low-Perfu...ance-based Uni.H.A., one of the largest healthcare...as signed a multi-year purchasing agreement for "g... The agreement offers preferred contract pricing t...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4
..., December 11 , - New ,Trophon EPR, Device ...ultrasound transducer disinfection are in many cas...he latest alarming result,issued by the Center for... US,public health agency, in its recently publishe...Healthcare Facilities (1). The guideline is the CD...
...1 Delcath Systems, Inc. (Nasdaq: DCTH ), a me...ercutaneous Hepatic Perfusion ("PHP") System for t...day that the first fifty percent (46 of 92) of pat... trial treating metastatic cutaneous and ocular me...cer centers in this trial continue to evaluate and...
... Alimera Sciences Inc., a privately held,biopharm..., development and,commercialization of prescriptio...enrollment has begun for a pilot study to assess t...with bilateral geographic atrophy (GA) secondary t...The pilot study will compare two doses of Iluvien ...
Other Biology Technology:Ultrasound Transducer Disinfection in Many Cases Insufficient 2Ultrasound Transducer Disinfection in Many Cases Insufficient 3Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point 2Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point 3Alimera Sciences Begins Pilot Study to Assess Safety and Efficacy of Iluvien(TM) in Patients With Bilateral Geographic Atrophy Due to AMD 2
(Date:11/19/2009)... with an unwieldy name: 4-hydroxybutyrate (4-HB). ...-rape drug. , Now, a team of Ohio and Michigan ...B is metabolized by the body. "This is new and imp...ssor and chair of biological sciences at Michigan ...rch team. "It may provide new clues on how to cou...
(Date:11/19/2009)...2: The offspring of two inbred strains tend to be ...the gene-level variability that leads to this phen...boost our ability to custom-tailor crops for speci... consumption or high glucose content for biomass f...quence of the common corn strain B73, University o...
(Date:11/19/2009)...nable farming, initially adopted to preserve soil ...le in maintaining a healthy climate, according to ...e and Los Alamos national laboratories. , ORNL a...al of the earth,s soils to sequester carbon, with ...ld greatly reduce U.S. carbon emissions by as much...
Breaking Biology News(10 mins):Researchers begin to decipher metabolism of sexual assault drug 2U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Seattle Childrens Hospital Deploys CAs Integrated Infrastructure and Performance Management Solution 52930 1Seattle Childrens Hospital Deploys CAs Integrated Infrastructure and Performance Management Solution 52930 2Seattle Childrens Hospital Deploys CAs Integrated Infrastructure and Performance Management Solution 52930 3Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 1Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 2Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 3Must Haves for Your Summer Vacation Bag 52922 1Must Haves for Your Summer Vacation Bag 52922 2Must Haves for Your Summer Vacation Bag 52922 3
...ma Barkai will receive the Helen and Martin Kimmel.... 5 at the Weizmann Institute. The award is accomp...r five years. , Taking a chance on an experiment ... Living cells are, from this angle, great subjects...have all sorts of interesting consequences for man...
...e in the November 2007 issue of BioScience describ...llenges of green roofsroofs with a vegetated surfa...struct than a typical roof, a green roof can reduc...trol storm-water runoff. Green roofs also provide ... less common in the United States than in Japan an...
... Far removed from streams of gas-thirsty cars and ...er in global climate change. Circling the norther... - one of the largest ecosystems on earth - act as...vels. , Forest ecologists at the University of Wi...tors such as forest fires and climate influence ca...
Other Biology News:Weizmann Institute scientists discover: A 'risk distribution law' for evolution 2Wildfire drives carbon levels in northern forests 2
CORNING ROLLER BOTTLES, 850 CM2, PS, EASY GRIP CAP, STERILE from Sigma-Aldrich
...n be upgraded to the GenePix Autoloader 4200AL. Th...nalyzes, and saves results for up to 36 slides, th...e. Line-by-line autofocus ensures superior field u...es you complete flexibility to configure scanning ...
...rray data using Asuragens bioinformatics expertise...to extensive data analysis using the most up to da...ith the Gene Expression Profiling Service or from ...on and basic statistical analysis including public...
Illumina Custom Data Analysis Report from Asuragen, Inc.
Biology Products: